Altered cholinergic function in the basal forebrain of girls with Rett syndrome

Neuropediatrics

Volumn 30, Issue 3, 1999, Pages 125-129

  Wenk, Gary L ^a,b   Hauss Wegrzyniak, Beatrice ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acetylcholine; ChAT positive neurons; Nerve growth factor; Rett syndrome

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; CELL COUNT; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FEMALE; FOREBRAIN; HAND MOVEMENT; HUMAN; HUMAN TISSUE; MENTAL DEFICIENCY; NERVE CELL; PRIORITY JOURNAL; RETT SYNDROME;

EID: 0032790740     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973476     Document Type: Article

References (48)

1. Altar, C. A., Bakhit, C. Receptor-mediated transport of human recombinant nerve growth factor from olfactory bulb to forebrain cholinergic nuclei. Brain Res. 541, 82-88 (1991).
2. Anvret, M., Wahlstrom, J., Akesson, H. Genetic Considerations and Clues from Molecular Genetics. In: Hagberg, H., Anvret, M., Wahlstrom, J. (Eds.). Rett Syndrome - Clinical and Biological Aspects. London, MacKeith 99-107 (1993).
3. Armstrong, D. D. The neuropathology of Rett syndrome - Overview 1994. Neuropediatrics 26, 100-104 (1995).
4. Batchelor, P. E., Armstrong, D. M., Blaker, S. N., Gage, F. H. Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: response to fimbria-fornix transection. J. Comp. Neurol. 284, 187-204 (1989).
5. Bothwell, M. Tissue localization of nerve growth factor and nerve growth factor receptors. Curr. Top. Microbiol. Immunol. 165, 55-70 (1991).
6. Crutcher, K. A., Scott, S. A., Liang, S., Everson, W. V., Weingartner, J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's Disease. J. Neurosci. 13, 2540-2550 (1993).
7. Fehsel, K., Kroncke, K. D., Kolb, H., Kolb-Bachofen, V. In situ nick-translation detects focal apoptosis in thymuses of glucocorticoid- and lipopolysaccharide-treated mice. J. Histochem. Cytochem. 42, 613-619 (1994).
8. Fonnum, F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115, 465-472 (1969).
9. Gavrieli, Y., Sherman, Y., Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501 (1992).
10. Gelbard, H. A., Boustany, R. M., Schor, N. F. Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease. Pediatr. Neurol. 16, 93-97 (1997).
11. Hagberg, B. Clinical delineation of Rett syndrome variants. Neuropediatrics 26, 62 (1995).
12. Hagberg, B., Aicardi, J., Dias, K., Ramos, O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett syndrome: Report of 35 cases. Ann. Neurol. 14, 471-479 (1983).
13. Hagberg, B., Gantières, F., Hanefeld, F., Rett, A., Wilson, J. Rett syndrome: criteria for inclusion and exclusion. Brain Dev. 7, 372-373 (1985).
14. Hagberg, B., Witt-Engerstrom, I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am. J. Med. Gen. 24, 47-59 (1986).
15. Hefti, F., Dravid, A., Hartikka, J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293, 305-311 (1984).
16. Jellinger, K., Armstrong, D., Zoghbi, H. Y., Percy, A. K. Neuropathology of Rett syndrome. Acta Neuropathol. 76, 142-158 (1988).
17. Jellinger, K., Seitelberger, F. Neuropathology of Rett syndrome. Am. J. Med. Genet. 24, 259-288 (1986).
18. Kitt, C. A., Troncoso, J. C., Price, D. L., Naidu, S., Moser H. W. Pathological changes in substantia nigra and basal forebrain neurons in Rett syndrome. Ann. Neurol. 28, 416-417 (1990).
19. Kitt, C. A., Wilcox, B. J. Preliminary evidence for neurodegenerative changes in the substantia nigra of Rett syndrome. Neuropediatrics 26, 114-118 (1995).
20. Korsching, S., Thoenen, H. Two-site immunoassay for nerve growth factor. Methods Enzymol. 147, 167-185 (1987).
21. Knüsel, B., Winslow, J. W., Rosenthal, A., Burton, L. E., Seid, D. P., Nikolics, K., et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc. Natl. Acad. Sci. USA 88, 961-965 (1991).
22. Lane, S. C., Jolly, R. D., Schmechel, D. E., Alroy, J., Boustany, R.-M. Apoptosis as the mechanism of neurodegeneration in Batten's disease. J. Neurochem. 67, 677-683 (1996).
23. Lappalainen, R., Lindholm, D., Rükonen, R. Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J. Child Neurol. 11, 296-300 (1996).
24. Larsson, L. I. Immunocytochemistry: Theory and Practice, Boca Raton, CRC Press (1988)
25. Masson, P. Carcinoids (Argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am. J. Pathol. 4, 181-211 (1928).
26. Mesulam, M.-M. Central cholinergic pathways: Neuroanatomy and some behavioral implications, In: Avoli, M., Reader, T. A., Dykes, R. W., Gloor, P., (Eds.). Neurotransmitters and Cortical Function: From Molecules to Mind. New York, Plenum Press 237-260 (1988).
27. Migeon, B. R., Dunn, M. A., Thomas, G., Schmeckpeper, B. J., Naidu, S. Studies of X inactivation and isodisomy in twins provide further evidence that the X chromosome is not involved in Rett syndrome. Am. J. Hum. Genet. 56, 647-653 (1995).
28. Mobley, W. C., Rutkowski, J. L., Tennekoon, G. I., Gemski, J., Buchanan, K., Johnston, M. V. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Molec Brain Res. 1, 53-62 (1986).
29. Naidu, S., Wong, D. F., Kitt, C., Wenk, G., Moser, H. W. Positron emission tomography in the Rett syndrome: clinical, biochemical and pathological correlates. Brain Dev. 14, S 75-S 79 (1992).
30. Oldfors, A., Sourander, P., Armstrong, D. L., Percy, A. K., Witt-Engerstrom, I., Hagberg, B. A. Rett syndrome: cerebellar pathology. Pediatr. Neurol. 6, 310-314 (1990).
31. Percy, A. K. Neurochemistry of the Rett syndrome. Brain Dev. 14, 57-62 (1992).
32. Petito, C. K., Roberts, B. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146, 1121-1130 (1995).
33. Qin, Z.-H., Wang, Y., Chase, T. N. Stimulation of N-methyl-D-aspartate receptors induces apoptosis in rat brain. Brain Res. 725, 166-176 (1996).
34. Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann. Neurol. 23, 425-428 (1988).
35. Rett, A. Über ein zerebral-atrophisches Syndrom bei Hyperammonämie. Wien. Med. Wschr. 116, 723-726 (1966).
36. Riederer, P., Brucke, T., Sofic, E., Kienzl, E., Schnecker, K., Schay, V., et al. Neurochemical aspects of the Rett syndrome. Brain Dev. 7, 351-360 (1985).
37. Seiler, M., Schwab, M. E. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300, 33-39 (1984).
38. Steriade, M., Buzsaki, G. Parallel activation of thalamic and cortical neurons by brain stem and basal forebrain cholinergic systems. In: Steriade, M., Biesold, D. (Eds.): Brain Cholinergic Systems. New York, Oxford University Press 3-62 (1990).
39. Suzaki, I., Hara, T., Maegaki, Y., Narai, S., Takeshita, K. Nerve growth factor in cerebrospinal fluid from patients with neurologic disorders. J. Child Neurol. 12, 205-207 (1997).
40. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462 (1995).
41. Wenk, G. L. Rett syndrome: A review of the neurobiological changes that underlie specific symptoms. Prog. Neurobiol. 51, 383-391 (1997).
42. Wenk, G. L., Mobley, S. L. Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions. Neurosci. 73, 79-84 (1996).
43. Wenk, G. L., Naidu, S., Casanova, M. F., Kitt, C. A., Moser, H. Altered neurochemical markers in Rett's syndrome. Neurol. 41, 1753-1756 (1991).
44. Wenk, G. L., O'Leary, M., Nemeroff, C. B., Bissette, G., Moser, H., Naidu, S. Neurochemical alterations in Rett syndrome. Dev. Brain Res. 74, 67-72 (1993).
45. Wenk, G. L., Stoehr, J. D., Quintana, G., Mobley, S. L., Wiley, R. G. Behavioral, biochemical, histological and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14, 5986-5995 (1994).
46. Wijsman, J. H., Jonker, R. R., Keijzer, R., VandeVelde, C. J. H., Cornelisse, C. J., Van Dierendonck, J. H. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 41, 7-12 (1993).
47. Wood, K. A., Dipasquale, B., Youle, R. J. In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron. 11, 621-632 (1993).
48. Yan, G. M., Lin, S. Z., Irwin, R. P., Paul, S. M. Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons. Molec. Pharmacol. 47, 248-257 (1995).